ACNOR

This brand name is authorized in the following countries: Turkey

Active ingredients

The drug ACNOR contains one active pharmaceutical ingredient (API):

UNII T58MSI464G - ACARBOSE

Acarbose is an alpha-glucosidase inhibitors, used in the treatment of diabetes. Inhibitors of a-glucosidase retard the breakdown of carbohydrates in the food and reduce the increase in blood glucose levels, which occurs after each meal.

Read about Acarbose

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
A10BF01
Acarbose
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BF Alpha glucosidase inhibitors
Discover more medicines within A10BF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
TR
ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu
Identifier(s): 8680881010880, 8680881010897, 8680881010903, 8680881010910, 8680881010927, 8680881010934

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈